| Dr Sean Michael Verlander, MD | |
|
27500 168th Pl Se, Covington, WA 98042-5563 | |
| (253) 395-2006 | |
| (253) 395-1977 |
| Full Name | Dr Sean Michael Verlander |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 27500 168th Pl Se, Covington, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851657514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD60552941 (Washington) | Primary |
| Entity Name | Valley Medical Group-renton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619209574 PECOS PAC ID: 4183753965 Enrollment ID: O20100604000113 |
News Archive
Schering-Plough Corporation today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to enjoin the planned merger with Merck & Co., Inc., and other forms of relief.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
The frontal lobes are the largest part of the human brain, and thought to be the part that expanded most during human evolution. Damage to the frontal lobes-which are located just behind and above the eyes-can result in profound impairments in higher-level reasoning and decision making. To find out more about what different parts of the frontal lobes do, neuroscientists at the California Institute of Technology (Caltech) recently teamed up with researchers at the world's largest registry of brain-lesion patients.
JDRF and BD today announced an extension of their existing collaboration focused on Type 1 diabetes (T1D) to accelerate the development of BD's proprietary glucose-sensing technology which has shown promise in providing very accurate and reliable continuous glucose information.
The debate on how to select patients who will respond best to costly drug treatments for aggressive breast cancer now favors fluorescence in situ hybridization (FISH) to measure the HER-2 receptor found in human breast tumors, according to a leading pathologist presenting at the Association for Molecular Pathology annual meeting.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sean Michael Verlander, MD Po Box 34876, Seattle, WA 98124-1876 Ph: (425) 656-5412 | Dr Sean Michael Verlander, MD 27500 168th Pl Se, Covington, WA 98042-5563 Ph: (253) 395-2006 |
News Archive
Schering-Plough Corporation today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to enjoin the planned merger with Merck & Co., Inc., and other forms of relief.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
The frontal lobes are the largest part of the human brain, and thought to be the part that expanded most during human evolution. Damage to the frontal lobes-which are located just behind and above the eyes-can result in profound impairments in higher-level reasoning and decision making. To find out more about what different parts of the frontal lobes do, neuroscientists at the California Institute of Technology (Caltech) recently teamed up with researchers at the world's largest registry of brain-lesion patients.
JDRF and BD today announced an extension of their existing collaboration focused on Type 1 diabetes (T1D) to accelerate the development of BD's proprietary glucose-sensing technology which has shown promise in providing very accurate and reliable continuous glucose information.
The debate on how to select patients who will respond best to costly drug treatments for aggressive breast cancer now favors fluorescence in situ hybridization (FISH) to measure the HER-2 receptor found in human breast tumors, according to a leading pathologist presenting at the Association for Molecular Pathology annual meeting.
› Verified 8 days ago
Dr. Callie Anne Byrd, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 27500 168th Pl Se, Covington, WA 98042 Phone: 425-690-3430 Fax: 425-690-9430 | |
Mai Nitta, Pediatrics Medicare: Medicare Enrolled Practice Location: 17700 Se 272nd St # 440, Covington, WA 98042 Phone: 253-372-7155 | |
Cheryl L Tan-jacobson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 17700 Se 272nd St, Covington, WA 98042 Phone: 253-372-7156 |